Fennec Provides Business Update and Announces Fiscal Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
Fennec Pharmaceuticals (FENC) Misses Q4 EPS by 1c
March 13, 2019 6:23 AM EDTFennec Pharmaceuticals (NASDAQ: FENC) reported Q4 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14).
Fourth Quarter and Year End 2018 Financial Results
Cash Position - Cash and cash equivalents were $22.8 million as of December 31, 2018.Research & Development (R&D) Expenses - R&D expenses were $1.7 million and $5.0 million, respectively, for the fourth quarter and year ended December 31, 2018, compared to $0.8 million and $1.9... More